List of Excipients in API doravirine, lamivudine, and tenofovir disoproxil fumarate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing doravirine, lamivudine, and tenofovir disoproxil fumarate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | DELSTRIGO | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 | CARNAUBA WAX | 2031-10-07 |
| Merck Sharp & Dohme LLC | DELSTRIGO | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 | CELLULOSE, MICROCRYSTALLINE | 2031-10-07 |
| Merck Sharp & Dohme LLC | DELSTRIGO | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 | CROSCARMELLOSE SODIUM | 2031-10-07 |
| Merck Sharp & Dohme LLC | DELSTRIGO | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 | FERRIC OXIDE YELLOW | 2031-10-07 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for doravirine, lamivudine, and tenofovir disoproxil fumarate
Excipient focus: CARNAUBA WAX
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | doravirine, lamivudine, and tenofovir disoproxil fumarate | 0006-5007 |
| >Company | >Ingredient | >NDC |
doravirine, lamivudine, and tenofovir disoproxil fumarate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
